The Pharmaceuticals and Medical Devices Agency (PMDA) announced that the SHINSA companion diagnostic (CDx) has received approval for use in identifying patients who are eligible for certain treatments. The approval was updated on June 16, 2026. Further details are available on the PMDA website.
규제 업데이트2026년 8월 23일•1분 읽기
PMDA Approves SHINSA CDx for Identifying Eligible Patients
Japan’s PMDA has approved the SHINSA companion diagnostic (CDx) to help identify patients eligible for specific therapies, updated June 16, 2026.
PharmaCountry 팀이 정리했습니다 · 출처: PMDA Japan
평점
(0)
(0)
(0)
(0)
(0)
평가 남기기